Fiduciary Trust’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-912
| Closed | -$111K | – | 521 |
|
|
2017
Q2 | $111K | Buy |
+912
| New | +$111K | ﹤0.01% | 522 |
|
|
2016
Q2 | – | Sell |
-1,531
| Closed | -$213K | – | 437 |
|
|
2016
Q1 | $213K | Buy |
1,531
+40
| +3% | +$5.57K | 0.01% | 405 |
|
|
2015
Q4 | $285K | Sell |
1,491
-788
| -35% | -$151K | 0.01% | 335 |
|
|
2015
Q3 | $357K | Buy |
2,279
+11
| +0.5% | +$1.72K | 0.02% | 307 |
|
|
2015
Q2 | $410K | Hold |
2,268
| – | – | 0.02% | 277 |
|
|
2015
Q1 | $393K | Sell |
2,268
-100
| -4% | -$17.3K | 0.02% | 278 |
|
|
2014
Q4 | $438K | Hold |
2,368
| – | – | 0.02% | 269 |
|
|
2014
Q3 | $393K | Buy |
2,368
+18
| +0.8% | +$2.99K | 0.02% | 258 |
|
|
2014
Q2 | $367K | Hold |
2,350
| – | – | 0.02% | 265 |
|
|
2014
Q1 | $358K | Sell |
2,350
-150
| -6% | -$22.9K | 0.02% | 257 |
|
|
2013
Q4 | $332K | Hold |
2,500
| – | – | 0.01% | 251 |
|
|
2013
Q3 | $290K | Hold |
2,500
| – | – | 0.01% | 260 |
|
|
2013
Q2 | $231K | Buy |
+2,500
| New | +$231K | 0.01% | 280 |
|